Dazucorilant 150 mg ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
2筋萎縮性側索硬化症1

2. 筋萎縮性側索硬化症


臨床試験数 : 645 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05407324
(ClinicalTrials.gov)
November 15, 20222/6/2022Dazucorilant in Patients With Amyotrophic Lateral SclerosisA Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of CORT113176 (Dazucorilant) in Patients With Amyotrophic Lateral Sclerosis (DAZALS)Amyotrophic Lateral SclerosisDrug: Dazucorilant 300 mg;Drug: Dazucorilant 150 mg;Other: PlaceboCorcept TherapeuticsNULLRecruiting18 YearsN/AAll198Phase 2Belgium;France;Netherlands;Poland